Polo Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 12-08-2024
- Paid Up Capital ₹ 1.32 M
as on 12-08-2024
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.07 Cr
as on 12-08-2024
- Revenue 174.31%
(FY 2023)
- Profit 41.01%
(FY 2023)
- Ebitda 26.34%
(FY 2023)
- Net Worth 8.09%
(FY 2023)
- Total Assets 34.79%
(FY 2023)
About Polo Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.32 M.
The company currently has active open charges totaling ₹3.07 Cr.
Suresh Kumar and Shobha Rani serve as directors at the Company.
- CIN/LLPIN
U24239HP1995PTC017140
- Company No.
017140
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- LocationHimachal Pradesh, Himachal Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Polo Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Kumar  | Director | 10-Oct-1995 | Current |
| Shobha Rani | Director | 10-Oct-1995 | Current |
Financial Performance of Polo Pharmaceuticals.
Polo Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 174.31% increase. The company also saw a substantial improvement in profitability, with a 41.01% increase in profit. The company's net worth moved up by a moderate rise of 8.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Polo Pharmaceuticals?
Unlock access to Polo Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Sep 2023 | ₹1.98 Cr | Open |
Union Bank Of India Creation Date: 28 Feb 2015 | ₹8.00 M | Open |
Union Bank Of India Creation Date: 09 Nov 2013 | ₹0.75 M | Open |
How Many Employees Work at Polo Pharmaceuticals?
Unlock and access historical data on people associated with Polo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Polo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polo Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
